Article ID Journal Published Year Pages File Type
5599214 Artery Research 2017 4 Pages PDF
Abstract

- Spironolactone and eplerenone, both were effective in reducing blood pressure.
- Both treatments reduced levels of inflammatory markers (hsCRP and TNF-α).
- Both were not effective in improving endothelial function.
- Both treatments did not reduce progression of carotid IMT and stiffness indices.
- Eplerenone was not found more effective than spironolactone or vice-versa.
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Authors
, , , ,